158459-39-3
158459-39-3
Chemical Structure
FE100726
- CAS No.: 158459-39-3
- Formula:C40H44N4O7
- Molecular Weight:692.80
SMILES: O=C(N(C1=CC=CC=C1C2)[C@H]2C(N([C@H](C3=CC=CC=C3)CC4)[C@H]4C(N(CC5=C(C6)C=CC=C5)[C@H]6C(N(CCC7)[C@@H]7C(O)=O)=O)=O)=O)OC(C)(C)C
Biological Activity: FE100726 (Compound 39) is a Cholecystokinin 2 (CCK2) receptor agonist. FE100726 has a superior binding capacity on CCK2 receptor. FE100726 can induce gastric acid secretion in anaesthetized rat models. FE100726 can be used for diabetes research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
FE100726 | FE100726 (Compound 39) is a Cholecystokinin 2 (CCK2) receptor agonist. FE100726 has a superior binding capacity on CCK2 receptor. FE100726 can induce gastric acid secretion in anaesthetized rat models. FE100726 can be used for diabetes research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Kalindjian SB, et al. Strategies for the design of non-peptide CCK2 receptor agonist and antagonist ligand. Curr Top Med Chem. 2007;7(12):1195-204. [Content Brief]
- [2]. Semple G, et al. Identification and biological activity of novel peptidomimetic gastrin/CCK-B receptor agonists[J]. Bioorganic & Medicinal Chemistry Letters, 1996, 6(24): 2971-2976.
